Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial
Clinical trial NCT03941860 · COMPLETED
Trial details
- NCT number
- NCT03941860
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-16
- Primary completion
- 2023-08-06
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.